---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-050216"
form_type: "8-K"
ticker: "OGEN"
cik: "0001174940"
company_name: "ORAGENICS INC"
filed_at: "2024-12-16T23:59:59+00:00"
generated_at: "2026-05-29T02:47:59.042990+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Oragenics appoints CFO Janet Huffman as Interim CEO; Preferred conversion cancels $2.35M liquidation preference

## Summary
- J. Michael Redmond terminated as Interim CEO/President effective Dec 16, 2024; CFO Janet Huffman appointed as new Interim CEO and President.
- Shareholders approved increasing 2021 Equity Incentive Plan by 2M shares to total 3,166,667 shares.
- All remaining Series A (5,417,000) and Series B (4,050,000) preferred shares converted to ~22,000 common shares, eliminating $2.35M liquidation preference.
- Directors re-elected: Charles Pope, Frederick Telling, Alan Dunton, Robert Koski, John Gandolfo, Bruce Cassidy.
- Advisory vote on executive compensation passed with 1,931,906 for vs 365,871 against.

## SEC filing metadata
- accession: 0001493152-24-050216
- form_type: 8-K
- ticker: OGEN
- cik: 0001174940
- company_name: ORAGENICS INC
- filed_at: 2024-12-16T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 5.02, 5.07, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1174940/000149315224050216/0001493152-24-050216-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1174940/000149315224050216/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-050216
- JSON: https://secwatch.observer/filing/0001493152-24-050216.json
- Plain text: https://secwatch.observer/filing/0001493152-24-050216.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.